|

Evaluation of the PHENO4U Data Platform in Patients Undergoing Total Knee Arthroplasty

RECRUITINGSponsored by Aesculap AG
Actively Recruiting
SponsorAesculap AG
Started2022-09-28
Est. completion2027-06
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05302934

Summary

Prospective, multinational pilot study for evaluation of the Pheno4U data platform in Total Knee Arthroplasty (TKA) patients

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Patient undergoing a total knee arthroplasty with a B. Braun knee implant system
* Signed written informed consent
* Patient's willingness \& ability to use the "BPMpathway"sensor
* Patient's willingness \& ability to use the "4Patient" application

Exclusion Criteria:

* Patient age \< 18 years
* Patient not willing to participate at the further follow-up
* Pregnancy
* If intraoperatively an implant from a different manufacturer is used, the study patient has to be excluded from the study.

Conditions7

ArthritisChronic Instability of KneeDeformity KneeDegenerative OsteoarthritisPosttraumatic ArthropathyRheumatoid ArthritisStiffness of Knee

Browse More Trials

Arthritis trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.